Suchergebnisse - "Cao, Hong"

PubPharm (24)

1

Cadonilimab plus anlotinib effectively relieve rare cardiac angiosarcoma with multiple metastases : a case report and literature review

enthalten in: Clinical research in cardiology : official journal of the German Cardiac Society | 2024

von Zeng, Z. | Mei, Z. | Chen, M. | +5

2

Boosting the abscopal effect with chemoradiotherapy/immunotherapy combination in metastatic cervical cancer : a case report

enthalten in: Immunotherapy | 2023

von Zhang, W. | Chen, M. | Xiang, Q. | +4

3

An adult progressive Langerhans cell histiocytosis with central nervous system involvement for 10 years : A case report

enthalten in: eNeurologicalSci | 2023

von Liu, H. | Liu, Y. | Cao, H. | +1

4

Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome : A case report and review of the literature

enthalten in: Medicine | 2023

von Deng, J. | Liao, X. | Cao, H.

5

Primary membranous nephropathy in two siblings with one combined with anti-glomerular basement membrane disease : a case report

enthalten in: BMC nephrology | 2023

von Cheng, Y. | Jia, X. | Cao, H. | +8

6

Multidisciplinary Treatment for Severe Secondary Raynaud's Phenomenon : A Case Report

enthalten in: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih | 2022

von Leng, C. | Lin, G. | Cao, H. | +1

7

Rare pattern of Maisonneuve fracture : A case report

enthalten in: World journal of clinical cases | 2022

von Zhao, B. | Li, N. | Cao, H. | +2

8

Persistent response of an ovarian cancer patient after a short-term single-agent immunotherapy : a case report

enthalten in: Anti-cancer drugs | 2022

von Sun, S. | Sun, W. | Xiang, Q. | +9

9

Borderline mucinous tumor of testis : A case report

enthalten in: Asian journal of surgery | 2021

von Wang, Z. | Cao, H.

10

Case Report : SMARCB1 (INI-1)-Deficient Carcinoma of the Nasal Cavity with Pure Yolk Sac Tumor Differentiation and Elevated Serum AFP Levels

enthalten in: OncoTargets and therapy | 2021

von Li, C. | Han, Y. | Xu, K. | +3